Berry Wealth Group LP Purchases New Position in CME Group Inc. (NASDAQ:CME)

Berry Wealth Group LP acquired a new position in CME Group Inc. (NASDAQ:CME) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 16,034 shares of the financial services provider’s stock, valued at approximately $3,377,000. CME Group accounts for 3.1% of Berry Wealth Group LP’s holdings, making the stock its 14th largest holding.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in CME. Capital Advisors Ltd. LLC raised its stake in CME Group by 5.0% during the third quarter. Capital Advisors Ltd. LLC now owns 1,032 shares of the financial services provider’s stock valued at $207,000 after buying an additional 49 shares during the last quarter. Transcend Capital Advisors LLC grew its stake in shares of CME Group by 1.7% during the 4th quarter. Transcend Capital Advisors LLC now owns 2,995 shares of the financial services provider’s stock valued at $631,000 after purchasing an additional 50 shares during the period. Jaffetilchin Investment Partners LLC increased its holdings in CME Group by 1.7% during the third quarter. Jaffetilchin Investment Partners LLC now owns 3,022 shares of the financial services provider’s stock valued at $605,000 after buying an additional 51 shares during the last quarter. Fidelis Capital Partners LLC increased its stake in shares of CME Group by 3.9% in the 3rd quarter. Fidelis Capital Partners LLC now owns 1,400 shares of the financial services provider’s stock worth $280,000 after purchasing an additional 52 shares in the last quarter. Finally, West Michigan Advisors LLC raised its stake in shares of CME Group by 0.9% in the third quarter. West Michigan Advisors LLC now owns 6,328 shares of the financial services provider’s stock worth $1,267,000 after buying an additional 59 shares during the period. Hedge funds and other institutional investors own 87.75% of the company’s stock.

CME Group Stock Up 0.2 %

CME traded up $0.34 during trading hours on Wednesday, reaching $209.98. 627,780 shares of the stock traded hands, compared to its average volume of 1,763,750. The firm’s fifty day simple moving average is $214.65 and its two-hundred day simple moving average is $211.69. CME Group Inc. has a fifty-two week low of $175.73 and a fifty-two week high of $223.80. The company has a market cap of $75.59 billion, a price-to-earnings ratio of 23.85, a PEG ratio of 5.24 and a beta of 0.49. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.01 and a quick ratio of 1.02.

CME Group (NASDAQ:CME) last posted its quarterly earnings results on Wednesday, April 24th. The financial services provider reported $2.50 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.44 by $0.06. The business had revenue of $1.49 billion for the quarter, compared to analyst estimates of $1.48 billion. CME Group had a return on equity of 12.45% and a net margin of 56.84%. The business’s revenue was up 3.2% compared to the same quarter last year. During the same period in the prior year, the company posted $2.42 EPS. As a group, analysts forecast that CME Group Inc. will post 9.72 earnings per share for the current fiscal year.

CME Group Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 26th. Stockholders of record on Friday, March 8th were paid a $1.15 dividend. This is a boost from CME Group’s previous quarterly dividend of $1.10. The ex-dividend date was Thursday, March 7th. This represents a $4.60 annualized dividend and a dividend yield of 2.19%. CME Group’s dividend payout ratio is presently 52.33%.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently commented on the company. Morgan Stanley boosted their target price on CME Group from $222.00 to $225.00 and gave the stock an “equal weight” rating in a research report on Tuesday, April 9th. Deutsche Bank Aktiengesellschaft restated a “hold” rating and set a $210.00 target price (down previously from $235.00) on shares of CME Group in a research report on Friday, April 5th. The Goldman Sachs Group cut CME Group from a “neutral” rating to a “sell” rating and set a $195.00 price objective on the stock. in a research note on Wednesday, January 3rd. Rosenblatt Securities restated a “sell” rating and set a $187.00 price objective (up from $185.00) on shares of CME Group in a research note on Thursday, April 25th. Finally, Keefe, Bruyette & Woods boosted their price target on CME Group from $222.00 to $226.00 and gave the stock a “market perform” rating in a research note on Thursday, April 25th. Two research analysts have rated the stock with a sell rating, seven have issued a hold rating and two have issued a buy rating to the stock. According to MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $217.80.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.